SCHEMBL7981415

SCHEMBL7981415

Cc1cccc(C)c1-c1cc(N)cc2c1nc(N)c1cncn12

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.44
FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983005 0.92 LCK (0.50) LCK
SCHEMBL7981390 0.86 LCK (0.43) LCKFGFR1
SCHEMBL8472491 0.85 LCK (0.44) LCKFGFR1
SCHEMBL8469310 0.83 LCK (0.46) LCKFGFR1
SCHEMBL7983561 0.79 LCK (0.47) LCK
SCHEMBL8469801 0.78 LCK (0.50) LCK
SCHEMBL7987372 0.78 LCK (0.48) LCKFGFR1
SCHEMBL7983065 0.77 LCK (0.52) LCK
SCHEMBL7970478 0.73 LCK (0.41) LCK
SCHEMBL7969763 0.73 LCK (0.53) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed